Pharmaceutical composition for treating craniocerebral injury-induced mental disturbance and application thereof
A technology for mental disorders and craniocerebral injuries, applied in the field of medicine, can solve the problems that the treatment does not have the expected effect, and achieve the effect suitable for long-term use, with obvious effect and stable quality control
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] A pharmaceutical composition for treating mental disorders caused by craniocerebral injury, the pharmaceutical composition comprises the following raw materials formulated in parts by weight: 9 parts of cis-2-pentenol, 9 parts of 2-pyrazinylethanethiol , 101 parts of 4-tert-butylanisole.
Embodiment 2
[0037] A pharmaceutical composition for treating mental disorders caused by craniocerebral injury, the pharmaceutical composition comprises the following raw materials formulated in parts by weight: 102 parts of cis-2-pentenol, 8 parts of 2-pyrazinylethanethiol , 6 parts of 4-tert-butylanisole.
Embodiment 3
[0039] A pharmaceutical composition for treating mental disorders caused by craniocerebral injury, the pharmaceutical composition comprises the following raw materials formulated in parts by weight: 8.5 parts of cis-2-pentenol, 102 parts of 2-pyrazinylethanethiol , 6.5 parts of 4-tert-butylanisole.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


